Levetiracetam
Product Images NDC 27241-007

11 FDA label images from Ajanta Pharma Limited · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Levetiracetam (NDC 27241-007). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ajanta Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Levetiracetam-fig1 (Levetiracetam Fig1)

Levetiracetam-fig1 (Levetiracetam Fig1)
A bar chart comparing the percentage of patients across three groups: Placebo, Levetiracetam Tablets 1000 mg/day, and Levetiracetam Tablets 3000 mg/day. The chart shows 7.4% for placebo, 37.1% for 1000 mg/day dosage, and 39.6% for 3000 mg/day dosage, depicting patient response rates or outcomes associated with each group.*
FDA Label Image

Levetiracetam-fig2 (Levetiracetam Fig2)

Levetiracetam-fig2 (Levetiracetam Fig2)
A bar chart comparing the percentage of patients across three groups: Placebo, Levetiracetam Tablets 1000 mg/day, and Levetiracetam Tablets 2000 mg/day. The Y-axis represents the percentage of patients from 0% to 45%, showing increased values for Levetiracetam groups compared to Placebo, with the highest at 35.2% for the 2000 mg/day dose.*
FDA Label Image

Levetiracetam-fig3 (Levetiracetam Fig3)

Levetiracetam-fig3 (Levetiracetam Fig3)
A bar chart comparing the percentage of patients for Placebo (14.4%) and Levetiracetam Tablets 3000 mg/day (39.4%). The x-axis labels the two groups with sample sizes (Placebo N=104, Levetiracetam Tablets N=180), and the y-axis shows the percentage of patients from 0% to 45%.*
FDA Label Image

Levetiracetam-fig4 (Levetiracetam Fig4)

Levetiracetam-fig4 (Levetiracetam Fig4)
A bar graph comparing the percentage of patients between two groups: Placebo and Levetiracetam Tablets. The y-axis represents the percentage of patients from 0% to 45%. The Placebo group (N=97) shows approximately 19.6%, while the Levetiracetam Tablets group (N=101) shows about 44.6%.*
FDA Label Image

Levetiracetam-fig5 (Levetiracetam Fig5)

Levetiracetam-fig5 (Levetiracetam Fig5)
A vertical bar chart comparing the percentage of patients between two groups: Placebo (N=51) with 19.6% and Levetiracetam Tablets (N=58) with 43.1%. The y-axis represents the percentage of patients, and the x-axis lists the two groups.*
FDA Label Image

Figure6 (Levetiracetam Figure6)

Figure6 (Levetiracetam Figure6)
A bar chart comparing the percentage of patients between two groups: Placebo (N=84) at 45.2% and Levetiracetam Tablets (N=79) at 72.2%. The y-axis represents the percentage of patients from 0% to 100%, illustrating patient response or outcome for each group.*
FDA Label Image

Str (Levetiracetam Str)

Str (Levetiracetam Str)
Chemical structure of levetiracetam showing a 2-oxo-1-pyrrolidineacetamide molecule with distinct ethyl, amide, and lactam functional groups.*
FDA Label Image

Levetiracetam_1000 (Levetiracetam 1000 60)

Levetiracetam_1000 (Levetiracetam 1000 60)
Levetiracetam Tablets USP 1000 mg label showing a 60-tablet container marketed by Ajanta Pharma USA Inc and manufactured by Ajanta Pharma Limited. The label includes storage instructions, pharmacist dispensing guidance, and states each film-coated tablet contains 1000 mg of levetiracetam.*
FDA Label Image

Levetiracetam_250mg (Levetiracetam 250 120)

Levetiracetam_250mg (Levetiracetam 250 120)
Levetiracetam Tablets USP 250 mg bottle label showing 120 tablets, manufactured by Ajanta Pharma Limited and marketed by Ajanta Pharma USA Inc. Includes storage instructions, pharmacist dispensing notes, and barcode.*
FDA Label Image

Levetiracetam_500mg (Levetiracetam 500 120)

Levetiracetam_500mg (Levetiracetam 500 120)
Label for Levetiracetam Tablets USP 500 mg by Ajanta Pharma Limited, packaged as 120 film-coated tablets. The label includes storage instructions, pharmacist dispensing guidelines, and manufacturer and marketer information. The NDC number 27241-008-12 and barcode are also visible.*
FDA Label Image

Levetiracetam_750mg (Levetiracetam 750 120)

Levetiracetam_750mg (Levetiracetam 750 120)
Label of Levetiracetam Tablets USP 750 mg, containing 120 film-coated tablets. The label shows the drug name, strength, and dosage form prominently. It also includes storage instructions, pharmacist dispensing guidelines, and manufacturer details: Ajanta Pharma Limited. The label features a barcode and the marketer's information: Ajanta Pharma USA Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.